http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11524182-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5ad8562c578b061df7a2c3aee9d0e24
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2007-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-2253
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2039-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2007-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2007-0078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2039-0276
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2007-0052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2007-0026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2007-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2007-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M39-0247
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-2251
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B8-0816
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N7-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N7-02
filingDate 2019-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f90ac936857d133006224af674f8b6eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b8a69192b5a440b9dec099e72df157a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e88b05cfab0c1bb9f946ecb6167451a
publicationDate 2022-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-11524182-B2
titleOfInvention Non-invasive treatment system using intermedium
abstract Disclosed herein is a non-invasive treatment system using intermedium, and an exemplary treatment system is configured to output high-intensity focused ultrasound to remove bone tissue, inject an acoustically-transparent medium into a part where the bone tissue is removed to generate an intermedium, and output therapeutic ultrasound that passes through the intermedium. Accordingly, the bone tissue is removed in a non-invasive way using high-intensity focused ultrasound, and the intermedium is generated at the bone tissue removed site, to increase the penetration of therapeutic ultrasound or generate ultrasound itself, thereby improving an ultrasound treatment effect while minimizing the side effect (for example, infection of dura mater) of invasive surgery methods.
priorityDate 2018-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007185231-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013204316-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012083717-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018177491-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007129652-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9044195-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011028867-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20110011914-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015151142-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411886

Total number of triples: 39.